Pfizer-owned cough syrup Corex banned in India
US pharmaceutical major Pfizer's India unit on Monday said that it has stopped selling its cough syrup Corex, after the Indian government banned it saying it was likely to pose a risk to humans. Corex is one of the 344 drug combinations the government banned on Saturday after a government panel of experts found they had "no therapeutic justification".